Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer

dc.contributor.author
Ramalho-Carvalho, João
dc.contributor.author
Graça, Inês
dc.contributor.author
Gómez, Antonio
dc.contributor.author
Oliveira, Jorge
dc.contributor.author
Henrique, Rui
dc.contributor.author
Esteller, Manel
dc.contributor.author
Jerónimo, Carmen
dc.date.issued
2019-02-06T16:38:52Z
dc.date.issued
2019-02-06T16:38:52Z
dc.date.issued
2017-02-06
dc.date.issued
2019-02-06T16:38:52Z
dc.identifier
1756-8722
dc.identifier
https://hdl.handle.net/2445/127981
dc.identifier
670729
dc.identifier
28166834
dc.description.abstract
Background: numerous DNA-damaging cellular stresses, including oncogene activation and DNA-damage response (DDR), may lead to cellular senescence. Previous observations linked microRNA deregulation with altered senescent patterns, prompting us to investigate whether epigenetic repression of microRNAs expression might disrupt senescence in prostate cancer (PCa) cells. Methods: differential methylation mapping in prostate tissues was carried using Infinium HumanMethylation450 BeadChip. After validation of methylation and expression analyses in a larger series of prostate tissues, the functional role of the cluster miR-130b~301b was explored using in vitro studies testing cell viability, apoptosis, invasion and DNA damage in prostate cancer cell lines. Western blot and RT-qPCR were performed to support those observations. Results: we found that the miR-130b~301b cluster directs epigenetic activation of cell cycle inhibitors required for DDR activation, thus stimulating the senescence-associated secretory phenotype (SASP). Furthermore, overexpression of miR-130b~301b cluster markedly reduced the malignant phenotype of PCa cells. Conclusions: altogether, these data demonstrate that miR-130b~301b cluster overexpression might effectively induce PCa cell growth arrest through epigenetic regulation of proliferation-blocking genes and activation of cellular senescence.
dc.format
13 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
BioMed Central
dc.relation
Reproducció del document publicat a: https://doi.org/10.1186/s13045-017-0415-1
dc.relation
Journal of Hematology & Oncology, 2017, vol. 10, num. 1, p. 43
dc.relation
https://doi.org/10.1186/s13045-017-0415-1
dc.rights
cc-by (c) Ramalho-Carvalho, João et al., 2017
dc.rights
http://creativecommons.org/licenses/by/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Ciències Fisiològiques)
dc.subject
Càncer de pròstata
dc.subject
Fenotip
dc.subject
Micro RNAs
dc.subject
Metilació
dc.subject
Cèl·lules canceroses
dc.subject
Envelliment
dc.subject
Prostate cancer
dc.subject
Phenotype
dc.subject
MicroRNAs
dc.subject
Methylation
dc.subject
Cancer cells
dc.subject
Aging
dc.title
Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.